FDA recall D-1304-2022

Glenmark Pharmaceuticals Inc., USA · Class III · drug

Product

Tacrolimus Ointment, 0.1%, For Dermatological Use Only, Not for Ophthalmic Use, Rx Only, a) 30 g tube, NDC 68462-534-35, b) 60 g tube, NDC 68462-534-65, c) 100 g tube, NDC 68462-534-94, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India.

Reason for recall

Defective Container: Tube split from side seam

Distribution

Nationwide in the USA

Key facts

Status
Ongoing
Initiation date
2022-07-11
Report date
2022-08-10
Voluntary/Mandated
Voluntary: Firm initiated
Location
Mahwah, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1304-2022